In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus

Antiviral Research

Volumn 92, Issue 2, 2011, Pages 237-246

  Wang, Wei ^a,b   Zhang, Pan ^a,b   Hao, Cui ^a,b   Zhang, Xian En ^c   Cui, Zong Qiang ^c   Guan, Hua Shi ^a,b  

^a Ocean University of China   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

^c WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Adsorption; Carrageenan oligosaccharide; Cell surface; Influenza A virus; Internalization

Indexed keywords

CARRAGEENAN; MESSENGER RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CARRAGEENAN; CELL LINE; DOGS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICROBIAL SENSITIVITY TESTS; MOLECULAR WEIGHT; OLIGOSACCHARIDES; VIRUS REPLICATION;

INFLUENZA A VIRUS;

EID: 80054875262     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.08.010     Document Type: Article

References (39)

1. Alam M.I. Investigation of the role of PKC-alpha for influenza A virus-induced signaling and of the inhibitory effect of Verapamil on virus replication. J. Biol. Chem. 2006, 281:16707-16715.
2. Artan M., Karadeniz F., Karagozlu M.Z., Kim M.M., Kim S.K. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr. Res. 2010, 345:656-662.
3. Basu D., Walkiewicz M.P., Frieman M., Baric R.S., Auble D.T., Engel D.A. Novel influenza virus NS1 antagonists block replication and restore innate immune function. J. Virol. 2009, 83:1881-1891.
4. Browne M.J. Mechanism and specificity of action of ribavirin. Antimicrob. Agents Chemother. 1978, 15:747-753.
5. Buck C.B., Thompson C.D., Roberts J.N., Muller M., Lowy D.R., Schiller J.T. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006, 2:e69.
6. Carlucci M.J., Scolaro L.A., Noseda M.D., Cerezo A.S., Damonte E.B. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antiviral Res. 2004, 64:137-141.
7. Chu V.C., Whittaker G.R. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc. Natl. Acad. Sci. USA 2004, 101(52):18153-18158.
8. Copeland R., Balasubramaniam A., Tiwari V., Zhang F.M., Bridges A., Linhardt R.J., Shukla D., Liu J. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 2008, 47:5774-5783.
9. Damonte E.B., Matulewicz M.C., Cerezo A.S. Sulfated seaweed polysaccharides as antiviral agents. Curr. Med. Chem. 2004, 11:2399-2419.
10. de Vries E., Tscherne D.M., Wienholts M.J., Cobos-Jimnéz V., Scholte F., Garci{dotless}á-Sastre A., Rottier P.J.M., de Haan C.A.M. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 2011, 7(3):e1001329.
11. Ekblad M., Adamiak B., Bergstrom T., Johnstone K.D., Karoli T., Liu L., Ferro V., Trybala E. A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus. Antiviral Res. 2010, 86:196-203.
12. Funami T., Hiroe M., Noda S., Asai I., Ikeda S., Nishinari K. Influence of molecular structure imaged with atomic force microscopy on the rheological behavior of carrageenan aqueous system in the presence or absence of cations. Food Hydrocolloid. 2007, 21:617-629.
13. Girond S., Crance J.M., Van Cuyck-Gandre H., Renaudet J., Deloince R. Antiviral activity of carrageenan on hepatitis A virus replication in cell culture. Res. Virol. 1991, 142:261-270.
14. Gonzalez M.E., Alarcon B., Carrasco L. Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob. Agents Chemother. 1987, 31:1388-1393.
15. Grassauer A., Weinmuellner R., Meier C., Pretsch A., Prieschl-Grassauer E., Unger H. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol. J. 2008, 5:107.
16. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985, 4:3021-3024.
17. Hayden F.G., Pavia A.T. Antiviral management of seasonal and pandemic influenza. J. Infect. Dis. 2006, 194(Suppl. 2):S119-S126.
18. Hung H.C., Tseng C.P., Yang J.M., Ju Y.W., Tseng S.N., Chen Y.F., Chao Y.S., Hsieh H.P., Shih S.R., Hsu J.T.A. Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res. 2009, 81:123-131.
19. Ji J., Wang L.C., Wu H., Luan H.M. Bio-function Summary of Marine Oligosaccharides. Int. J. Biol. 2011, 3:74-86.
20. Lagoja I.M., De Clercq E. Anti-influenza virus agents: synthesis and mode of action. Med. Res. Rev. 2008, 28:1-38.
21. Lamb R.A., Takeda M. Death by influenza virus protein. Nat. Med. 2001, 7:1286-1288.
22. Leibbrandt A., Meier C., König-Schuster M., Weinmüllner R., Kalthoff D., Pflugfelder B., Graf P., Frank-Gehrke B., Beer M., Fazekas T., Unger H., Prieschl-Grassauer E., Grassauer A. Iota-carrageenan is a potent inhibitor of influenza A virus infection. PLoS One 2010, 5:e14320.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 2001, 25:402-408.
24. Mendel D.B., Tai C.Y., Escarpe P.A., Li W.X., Sidwell R.W., Huffman J.H., Sweet C., Jakeman K.J., Merson J., Lacy S.A., Lew W., Williams M.A., Zhang L.J., Chen M.S., Bischofberger N., Kim C.U. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob. Agents Chemother. 1998, 42:640-646.
25. Miao B.C., Geng M.Y., Li J., Li F.C., Chen H.X., Guan H.S., Ding J. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes. Biochem. Pharmacol. 2004, 68:641-649.
26. Ning J., Zhang W., Yi Y., Yang G., Wu Z., Yi J., Kong F. Synthesis of β-(1→6)-Branched β-(1→3) glucohexaose and its analogues containing an α-(1→3) linked bond with antitumor activity. Bioorg. Med. Chem. 2003, 11:2193-2203.
27. Nyberg K., Ekblad M., Bergström T., Freeman C., Parish C.R., Ferro V., Trybala E. The low molecular weight heparan sulfate mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res. 2004, 63:15-24.
28. Pujol C.A., Scolaro L.A., Ciancia M., Matulewicz M.C., Cerezo A.S., Damonte E.B. Antiviral activity of a carrageenan from Gigartinatina skottsbergii against intraperitoneal murine herpes simplex virus infection. Planta Med. 2006, 72:121-125.
29. Reed L., Muench H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:943-947.
30. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
31. Talarico L.B., Damonte E.B. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 2007, 363:473-485.
32. Talarico L.B., Noseda M.D., Ducatti D.R.B., Duarte M.E., Damonte E.B. Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan. J. Gen. Virol. 2011, 92:1332-1342.
33. WHO, 2002. WHO Manual on Animal Influenza Diagnosis and Surveillance.
34. Wolkerstorfer A., Kurz H., Bachhofner N., Szolar O.H.J. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res. 2009, 83:171-178.
35. Wu S.H., Patel K.B., Booth L.J., Metcalf J.P., Lin H.K., Wu W.X. Protective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells. BMC Complement. Altern. Med. 2010, 10:69.
36. Yamada T., Ogamo A., Saito T., Watanabe J., Uchiyama H., Nakagawa Y. Preparation and anti-HIV activity of low-molecular-weight carrageenans and their sulfated derivatives. Carbohydr. Polym. 1997, 32(1):51-55.
37. Yamada T., Ogamo A., Saito T., Uchiyama H., Nakagawa Y. Preparation of O-acylated low-molecular-weight carrageenans with potent anti-HIV activity and low anticoagulant effect. Carbohydr. Polym. 2000, 41:115-120.
38. Yamamoto Y., Nunome T., Yamauchi R., Kato K., Sone Y. Structure of an exocellular polysaccharide of Lactobacillus helveticus TN-4, a spontaneous mutant strain of Lactobacillus helveticus TY1-2. Carbohydr. Res. 1995, 275:319-332.
39. Yewdell J., Garcia-Sastre A. Influenza virus still surprises. Curr. Opin. Microbiol. 2002, 5:414-418.